Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Mylan agrees to pay $335 million over nine years to settle claims of misleading opioid marketing.
Pharmaceutical company Mylan Inc., now part of Viatris, has agreed to pay $335 million over nine years to settle allegations of misleading marketing of its opioid products, which were falsely promoted as less prone to abuse.
The settlement, involving multiple states, aims to fund addiction treatment and prevention services.
States like Oregon and Virginia expect to receive millions to combat the opioid crisis.
12 Articles
Mylan está de acuerdo en pagar $335 millones durante nueve años para resolver reclamaciones de marketing de opioides engañosos.